Irritable bowel syndrome

Best Practice and Research: Clinical Gastroenterology

Volumn 18, Issue 2, 2004, Pages 315-321

  Verdu, Elena F ^a   Collins, Stephen M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Gut function; Intestinal microflora; Irritable bowel syndrome; Motility; Probiotics

Indexed keywords

BILE ACID; CYCLOOXYGENASE 2; PLACEBO; PROBIOTIC AGENT; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA1;

ARTHRITIS; BACTERIAL METABOLISM; BIFIDOBACTERIUM; CLINICAL TRIAL; COLORECTAL CANCER; COMMENSALISM; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; ENTERITIS; EXPERIMENTATION; FOOD; FUNCTIONAL DISEASE; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL SECRETION; GASTROINTESTINAL TRACT; GERMFREE ANIMAL; HOST PATHOGEN INTERACTION; HUMAN; INTESTINE FLORA; INTESTINE FUNCTION; INTESTINE FUNCTION DISORDER; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; LACTOBACILLUS CASEI; LACTOBACILLUS PLANTARUM; MODULATION; MORPHOLOGY; MOTOR DYSFUNCTION; NEUROMUSCULAR FUNCTION; NONHUMAN; REVIEW; ANIMAL; ANIMAL MODEL; ENTEROBACTERIACEAE; IMMUNOLOGY; MICROBIOLOGY; MOUSE;

ANIMALS; ENTEROBACTERIACEAE; HUMANS; IRRITABLE BOWEL SYNDROME; MICE; MODELS, ANIMAL; PROBIOTICS;

EID: 1842505585     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2003.11.003     Document Type: Review

References (31)

1. Balsari A. Ceccarelli A. Dubini F. et al. The fecal microbial population in the irritable bowel syndrome Microbiologica 5 1982 185-194
2. Bradley H.K. Wyatt G.M. Bayliss C.E. Hunter J.O. Instability in the faecal flora of a patient suffering from food-related irritable bowel syndrome Journal of Medical Microbiology 23 1987 29-32
3. Cummings J.H. Macfarlane G.T. The control and consequences of bacterial fermentation in the human colon Journal of Applied Bacteriology 70 1991 443-459
4. King T.S. Elia M. Hunter L.O. Abnormal colonic fermentation in irritable bowel syndrome Lancet 352 1998 1187-1189
5. Chaudhary N.A. Truelove S.C. The irritable colon syndrome Quarterly Journal of Medicine 123 1962 307-322
6. McKendrick M.W. Read N.W. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. Irritable bowel syndrome-post salmonella infection Journal of Infection 29 1999 1-33
7. Neal K.R. Hebden J. Spiller R. Prevalence of gastrointestinal symptoms six month after bacterial gastroenteritis, and risk factors for development of the irritable bowel syndrome: postal survey of patients British Medical Journal 314 1997 779-782
8. Rodriguez L.A. Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study British Medical Journal 318 1999 565-566
9. Gonsalkorale W.M. Perrey C. Pravica V. et al. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut 52 2003 91-93
10. Morris-Yates A. Talley N.J. Boyce P.M. et al. American Journal of Gastroenterology 93 1998 1311-1317
11. Levy R.L. Jones K.R. Whitehead W.E. et al. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology Gastroenterology 121 2001 799-804
12. Chadwick V.S. Chen W. Shu D. et al. Activation of the mucosal immune system in irritable bowel syndrome Gastroenterology 122 2002 1778-1783
13. Maxwell P.R. Rink E. Kumar D. Mendall M.A. Antibiotics increase functional abdominal symptoms American Journal of Gastroenterology 97 2002 104-108
14. Pimentel M. Chow E.J. Lin H.C. Eradication of small intestinal bacterial growth reduces symptoms of irritable bowel syndrome American Journal of Gastroenterology 95 2000 3503-3506
15. Isgar B. Harman M. Kaye M.D. Whorwell P.J. Symptoms of irritable bowel syndrome in ulcerative colitis in remission Gut 24 1983 190-192
16. Caenepeel P. Janssens J. Vantrappen G. et al. Interdigestive myoelectric complex in germ-free rats Digestive Diseases & Sciences 34 1989 1180-1184
17. Husebye E. Hellstrom P.M. Sundler F. et al. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats American Journal of Physiology, Gastrointestinal and Liver Physiology 280 2001 G368-G380
18. Huseybe E. Hellstrom P.M. Midtvedt T. Intestinal microflora stimulates myoelectric activity of rat intestine by promoting cyclic initiation and aboral propagation of migrating myoelectric complex Digestive Diseases & Sciences 39 1994 946-956
19. Nieuwenhuijs V.B. Verheem A. van Duijvenbode-Beumer H. et al. The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats Annals of Surgery 228 1998 188-193
20. Berg R.D. Bacterial translocation from the gastrointestinal tract Advances in Experimental Medicine - Biology 473 1999 11-30
21. McPherson AJ. Immune regulation of the normal intestinal bacterial flora. The host response to the normal intestinal flora. In: Uhr T, editor. Gut Ecology 2002.
22. Hooper L.V. Wong M.H. Thelin A. et al. Molecular analysis of commensal host-microbial relationships in the intestine Science 291 2001 881-884
23. Sen S. Mullan M.M. Parker T.J. et al. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome Digestive Diseases & Sciences 47 2002 2615-2620
24. Nobaeck S. Johansson M.-L. Molin G. et al. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome American Journal of Gastroenterology 95 2000 1231-1238
25. Niedzielin K. Kordecki H. Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299v in patients with irritable bowel syndrome European Journal of Gastroenterology & Hepatology 13 2001 1143-1147
26. O'Sullivan M.A. O'Morain C.A. Bacterial supplementation in the irritable bowel syndrome. A randomized, double-blind placebo-controlled cross-over study Digestive and Liver Disease 32 2000 302-304
27. Kim H.J. Camillieri M. McKinzie S. et al. A randomized controlled trial of a probiotic, VSL#3, on gut tr4ansit and symptoms in diarrhoea-predominant irritable bowel syndrome Alimentary Pharmacology & Therapeutics 17 2003 895-904
28. Barbara G. Vallance B.A. Collins S.M. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice Gastroenterology 113 1997 1224-1232
29. Akiho H. Deng Y. Blennerhassett P. et al. The roles of TGFβ and COX-2 in the maintenance of muscle hypercontractility in a murine model of post infective irritable bowel syndrome Gastroenterology 122 2002
30. Barbara G. De Giorgio R. Deng Y. et al. Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice Gastroenterology 120 2001 1729-1736
31. Verdu E.F. Bercik P. Blennerhasset P. et al. Strain dependent effects of probiotics on intestinal muscle dysfunction in an animal model of post-infective irritable bowel syndrome Gastroenterology 124 2003 A197